Rapid Androgen Cycling as Treatment for Patients with Prostate Cancer
Open Access
- 15 December 2006
- journal article
- clinical trial
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 12 (24), 7414-7421
- https://doi.org/10.1158/1078-0432.ccr-06-1496
Abstract
Purpose: To investigate the safety and feasibility of rapid androgen cycling for men with progressive prostate cancer.Keywords
This publication has 27 references indexed in Scilit:
- Prostate-Specific Antigen Nadir and Cancer-Specific Mortality Following Hormonal Therapy for Prostate-Specific Antigen FailureJournal of Clinical Oncology, 2005
- Timing Is Everything: Preclinical Evidence Supporting Simultaneous Rather Than Sequential Chemohormonal Therapy for Prostate CancerClinical Cancer Research, 2005
- Long-Term Outcomes in Patients with Prostate Cancer Managed with Intermittent Androgen SuppressionUrologia Internationalis, 2004
- Cell proliferation and apoptosis in prostate tumors and adjacent non‐malignant prostate tissue in patients at different time‐points after castration treatmentThe Prostate, 2004
- Engineering cross-presentation in vivoExpert Opinion on Biological Therapy, 2003
- Apoptosis levels increase after castration in the CWR22 human prostate cancer xenograftThe Prostate, 2003
- CTLA-4: new insights into its biological function and use in tumor immunotherapyNature Immunology, 2002
- Androgen Receptor Expression and Cellular Proliferation During Transition from Androgen-Dependent to Recurrent Growth after Castration in the CWR22 Prostate Cancer XenograftThe American Journal of Pathology, 2002
- Intermittent androgen deprivation therapy: schedule modifications based on a novel in vivo human xenograft modelProstate Cancer and Prostatic Diseases, 2000
- KETOCONAZOLE THERAPY FOR ADVANCED PROSTATE CANCERThe Lancet, 1984